HRS-8080 Tablet

DRUG3 trials

Sponsors

Shandong Suncadia Medicine Co., Ltd.

Conditions

Advanced Unresectable or Metastatic Breast Cancer of AdultsBreast CancerLocally Advanced Breast CancerMetastatic Breast Cancer

Phase 1

A Trial of Itraconazole Effect on HRS-8080 Pharmacokinetics in Healthy Participants

CompletedNCT07229560

Shandong Suncadia Medicine Co., Ltd.Breast Cancer

Start: 2025-11-26End: 2025-12-31Updated: 2026-01-14

A Study of HRS-6208 in Combination With HRS-8080, or Fulvestrant, or Letrozole, With or Without HRS-6209 in Patients With Advanced Unresectable or Metastatic Breast Cancer

RecruitingNCT07389733

Shandong Suncadia Medicine Co., Ltd.Advanced Unresectable or Metastatic Breast Cancer of Adults

Start: 2026-03-27End: 2028-12-01Target: 180Updated: 2026-04-03

Phase 3

A Phase 3 Study of HRS-8080 Versus Treatment Chosen by Physicians in Locally Advanced and Metastatic Breast Cancer

RecruitingNCT07024173

Shandong Suncadia Medicine Co., Ltd.Locally Advanced Breast Cancer, Metastatic Breast Cancer

Start: 2025-07-23End: 2027-12-01Target: 240Updated: 2026-01-26